Clovis Oncology Inc (NASDAQ:CLVS)

2.87
Delayed Data
As of Jul 01
 +1.07 / +59.44%
Today’s Change
0.58
Today|||52-Week Range
5.92
+5.90%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Rolfe Lindsey
Corporate Officer
Sale3/02/202210,585$1.87$19.8K+55.74%
Gross Paul Edward
Corporate Officer
Sale3/02/202210,416$1.87$19.5K+55.74%
Muehl Daniel W
Corporate Officer
Sale3/02/202210,416$1.87$19.5K+55.74%
Ivers Read Gillian C
Corporate Officer
Sale3/02/202210,416$1.87$19.5K+55.74%
Harding Thomas Colum
Corporate Officer
Sale3/02/20226,780$1.87$12.7K+55.74%
Gross Paul Edward
Corporate Officer
Sale8/03/20212,473$4.82$11.9K-41.36%
Muehl Daniel W
Corporate Officer
Sale8/03/20212,473$4.82$11.9K-41.36%
Gross Paul Edward
Corporate Officer
Sale11/02/20212,482$4.55$11.3K-40.13%
Muehl Daniel W
Corporate Officer
Sale11/02/20212,482$4.55$11.3K-40.13%
Rolfe Lindsey
Corporate Officer
Sale8/03/20212,317$4.82$11.2K-41.36%
Page of 16